Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Convertible Preferred Shares and Shareholders' (Deficit) / Equity

v3.20.4
Consolidated Statements of Convertible Preferred Shares and Shareholders' (Deficit) / Equity - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Series B Convertible Preferred Shares
IPO
Ordinary Shares
Ordinary Shares
Convertible Preferred Stock
Ordinary Shares
IPO
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Accumulated Deficit
Beginning balance at Dec. 31, 2017 $ 39,494       $ 4     $ 94,227   $ (54,737)
Temporary Equity beginning balance (in shares) at Dec. 31, 2017   5,686,663                
Temporary Equity beginning balance at Dec. 31, 2017   $ 57                
Beginning balance (in shares) at Dec. 31, 2017         413,110          
Issuance of Series B convertible preferred shares, net of issuance costs 32,159             32,159    
Temporary equity,Issuance of convertible preferred shares,net of issuance costs (in shares)     1,709,650              
Temporary equity,Issuance of convertible preferred shares,net of issuance costs     $ 17              
Issuance of shares       $ 74,153     $ 64   $ 74,089  
Issuance of shares (in shares)             6,350,000      
Exercise of share options $ 7             7    
Exercise of share options (in shares) 2,008       2,008          
Issuance of ordinary shares under subscription agreement $ 1,362       $ 2     1,360    
Issuance of ordinary shares under subscription agreement (in shares)         190,615          
Redenomination of share capital (42)         $ (42)        
Temporary equity,redenomination of share capital   $ 42                
Conversion of preferred shares to ordinary shares 116       $ 116          
Temporary equity conversion of convertible preferred stock (in shares)   (7,396,313)                
Temporary equity conversion of convertible preferred stock   $ (116)                
Conversion of preferred shares to ordinary shares (in shares)         7,396,313          
Issuance of warrants for ordinary shares 139             139    
Share-based compensation expense 1,290             1,290    
Net loss (77,056)                 (77,056)
Ending balance at Dec. 31, 2018 71,622       $ 144     203,271   (131,793)
Ending balance (in shares) at Dec. 31, 2018         14,352,046          
Issuance of ordinary shares in conjunction with vesting of restricted share units (in shares)         36,924          
Exercise of share options $ 60             60    
Exercise of share options (in shares) 18,232       18,232          
Issuance of ordinary shares under subscription agreement $ 3,037       $ 5     3,032    
Issuance of ordinary shares under subscription agreement (in shares)         461,771          
Share-based compensation expense 2,173             2,173    
Net loss (103,130)                 (103,130)
Ending balance at Dec. 31, 2019 (26,238)       $ 149     208,536   (234,923)
Ending balance (in shares) at Dec. 31, 2019         14,868,973          
Issuance of shares 13,332       $ 345     12,987    
Issuance of shares (in shares)         34,562,055          
Issuance of warrants for ordinary shares 11,594             11,594    
Share-based compensation expense 2,759             2,759    
Net loss (52,006)                 (52,006)
Ending balance at Dec. 31, 2020 $ (50,559)       $ 494     $ 235,876   $ (286,929)
Ending balance (in shares) at Dec. 31, 2020         49,431,028